Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32351
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorVogrin, S-
dc.contributor.authorMitri, Elise A-
dc.contributor.authorHall, R-
dc.contributor.authorCopaescu, Ana-
dc.contributor.authorWaldron, J-
dc.contributor.authorDe Luca, J-
dc.contributor.authorRose, Morgan T-
dc.contributor.authorMackay, G-
dc.contributor.authorLambros, B-
dc.contributor.authorDouglas, A P-
dc.contributor.authorHolmes, Natasha E-
dc.contributor.authorChua, Kyra Y L-
dc.date2023-
dc.date.accessioned2023-03-22T02:18:46Z-
dc.date.available2023-03-22T02:18:46Z-
dc.date.issued2023-07-05-
dc.identifier.citationClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 2023; 77(1)en_US
dc.identifier.issn1537-6591-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32351-
dc.description.abstractInpatient direct oral challenge programs are increasingly deployed as part of antimicrobial stewardship (AMS) initiatives to reduce the burden and impacts of penicillin allergy labels on antibiotic prescribing. Using data from a prospective multicentre cohort inpatient penicillin allergy program, we identify the key targets for delabeling to aid health service implementation.en_US
dc.language.isoeng-
dc.subjectamoxicillin allergyen_US
dc.subjectantimicrobial stewardshipen_US
dc.subjectbeta-lactam allergyen_US
dc.subjectdrug allergyen_US
dc.subjectoral provocationen_US
dc.titleThe Who, What, When and Where of Inpatient Direct Oral Penicillin Challenge - Implications for health services implementation.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of Americaen_US
dc.identifier.affiliationCentre for Antibiotic Allergy and Researchen_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationAlbury Wodonga Health, Albury, NSW 2640.en_US
dc.identifier.affiliationPharmacyen_US
dc.identifier.affiliationData Analytics Research and Evaluation (DARE) Centreen_US
dc.identifier.doi10.1093/cid/ciad156en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-5111-6367en_US
dc.identifier.pubmedid36929823-
local.name.researcherChua, Kyra Y L
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
crisitem.author.deptPharmacy-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
crisitem.author.deptMicrobiology-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

136
checked on Nov 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.